| For: | Caparello C, Meijer LL, Garajova I, Falcone A, Le Large TY, Funel N, Kazemier G, Peters GJ, Vasile E, Giovannetti E. FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancer. World J Gastroenterol 2016; 22(31): 6987-7005 [PMID: 27610011 DOI: 10.3748/wjg.v22.i31.6987] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i31/6987.htm |
| Number | Citing Articles |
| 1 |
Aurélien Lambert, Céline Gavoille, Thierry Conroy. Current status on the place of FOLFIRINOX in metastatic pancreatic cancer and future directions. Therapeutic Advances in Gastroenterology 2017; 10(8) doi: 10.1177/1756283X17713879
|
| 2 |
Ingrid Hilger. Magnetic Materials and Technologies for Medical Applications. 2022; doi: 10.1016/B978-0-12-822532-5.00018-2
|
| 3 |
Dimitrios Stefanoudakis, Maximos Frountzas, Dimitrios Schizas, Nikolaos V. Michalopoulos, Alexandra Drakaki, Konstantinos G. Toutouzas. Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer. Current Issues in Molecular Biology 2024; 46(4) doi: 10.3390/cimb46040177
|
| 4 |
Btissame El Hassouni, Giovanna Li Petri, Daniel S.K. Liu, Stella Cascioferro, Barbara Parrino, Waqar Hassan, Patrizia Diana, Asif Ali, Adam E Frampton, Elisa Giovannetti. Pharmacogenetics of treatments for pancreatic cancer. Expert Opinion on Drug Metabolism & Toxicology 2019; 15(6) doi: 10.1080/17425255.2019.1620731
|
| 5 |
Yaohui Fang, Chunlu Tan, Zhenjiang Zheng, Jianchen Yang, Jiali Tang, Ruizhe Guo, Epiphane K. Silli, Zhe Chen, Jia Chen, Ruyu Ge, Yuquan Liu, Xiuqi Wen, Jingdan Liang, Yunfei Zhu, Yutong Jin, Qian Li, Ying Wang. The function of microRNA related to cancer-associated fibroblasts in pancreatic ductal adenocarcinoma. Biochemical Pharmacology 2025; 236 doi: 10.1016/j.bcp.2025.116849
|
| 6 |
Tessa Ya Sung Le Large, Btissame El Hassouni, Geert Kazemier, Sander R. Piersma, Hanneke W. M. van Laarhoven, Maarten F. Bijlsma, Cornelia R. Jimenez, Elisa Giovannetti. Multidrug‐resistant transporter expression does not always result in drug resistance. Cancer Science 2018; 109(10) doi: 10.1111/cas.13756
|
| 7 |
Jisce R Puik, Laura L Meijer, Tessa YS Le Large, Mireia Mato Prado, Adam E Frampton, Geert Kazemier, Elisa Giovannetti. miRNA Profiling for Diagnosis, Prognosis and Stratification of Cancer Treatment in Cholangiocarcinoma. Pharmacogenomics 2017; 18(14) doi: 10.2217/pgs-2017-0010
|
| 8 |
Neal Bhutiani, Yan Li, Qianqian Zheng, Harshul Pandit, Xiaoju Shi, Yujia Chen, Youxi Yu, Zachary R. Pulliam, Min Tan, Robert C. G. Martin. Electrochemotherapy with Irreversible Electroporation and FOLFIRINOX Improves Survival in Murine Models of Pancreatic Adenocarcinoma. Annals of Surgical Oncology 2020; 27(11) doi: 10.1245/s10434-020-08782-2
|
| 9 |
T.Y.S. Le Large, M.F. Bijlsma, G. Kazemier, H.W.M. van Laarhoven, E. Giovannetti, C.R. Jimenez. Key biological processes driving metastatic spread of pancreatic cancer as identified by multi-omics studies. Seminars in Cancer Biology 2017; 44 doi: 10.1016/j.semcancer.2017.03.008
|
| 10 |
Tessa Y.S. Le Large, Laura L. Meijer, Rosita Paleckyte, Lenka N.C. Boyd, Bart Kok, Thomas Wurdinger, Tim Schelfhorst, Sander R. Piersma, Thang V. Pham, Nicole C.T. van Grieken, Barbara M. Zonderhuis, Freek Daams, Hanneke W.M. van Laarhoven, Maarten F. Bijlsma, Connie R. Jimenez, Elisa Giovannetti, Geert Kazemier. Combined Expression of Plasma Thrombospondin-2 and CA19-9 for Diagnosis of Pancreatic Cancer and Distal Cholangiocarcinoma: A Proteome Approach. The Oncologist 2020; 25(4) doi: 10.1634/theoncologist.2019-0680
|
| 11 |
Monique Williams, Gwen Lomberk, Raul Urrutia. Pancreatic Cancer. 2017; doi: 10.1007/978-1-4939-6631-8_15-2
|
| 12 |
Btissame El Hassouni, Giulia Mantini, Benoît Immordino, Godefridus J. Peters, Elisa Giovannetti. CX-5461 Inhibits Pancreatic Ductal Adenocarcinoma Cell Growth, Migration and Induces DNA Damage. Molecules 2019; 24(24) doi: 10.3390/molecules24244445
|
| 13 |
Guido Giordano, Massimo Pancione, Nunzio Olivieri, Pietro Parcesepe, Marianna Velocci, Tania Di Raimo, Luigi Coppola, Giuseppe Toffoli, Mario Rosario D’Andrea. Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directions. World Journal of Gastroenterology 2017; 23(32): 5875-5886 doi: 10.3748/wjg.v23.i32.5875
|
| 14 |
Mjriam Capula, Macarena Perán, Geng Xu, Valentina Donati, Dicky Yee, Alessandro Gregori, Yehuda G. Assaraf, Elisa Giovannetti, Dongmei Deng. Role of drug catabolism, modulation of oncogenic signaling and tumor microenvironment in microbe-mediated pancreatic cancer chemoresistance. Drug Resistance Updates 2022; 64 doi: 10.1016/j.drup.2022.100864
|
| 15 |
Rosa Wijnen, Camilla Pecoraro, Daniela Carbone, Hamid Fiuji, Amir Avan, Godefridus J. Peters, Elisa Giovannetti, Patrizia Diana. Cyclin Dependent Kinase-1 (CDK-1) Inhibition as a Novel Therapeutic Strategy against Pancreatic Ductal Adenocarcinoma (PDAC). Cancers 2021; 13(17) doi: 10.3390/cancers13174389
|
| 16 |
Yongheng Shu, Ping Cheng. Targeting tumor-associated macrophages for cancer immunotherapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1874(2) doi: 10.1016/j.bbcan.2020.188434
|
| 17 |
Akhileshwar Kumar Srivastava, Dhruv Kumar, Divya Singh, Rajesh Kumar Singh. Xenobiotics in Chemical Carcinogenesis. 2022; doi: 10.1016/B978-0-323-90560-2.00011-X
|
| 18 |
Mohini Singh, Niva Rani Gogoi, Bani K. Jana, Tumpa Sarkar, Venessa Nath, Bhaskar Mazumder. Drug Delivery Landscape in Cancer Research. 2025; doi: 10.1016/B978-0-443-29168-5.00002-7
|
| 19 |
Rong-Jane Chen, Yi-Jhen Lyu, Yu-Ying Chen, Yen-Chien Lee, Min-Hsiung Pan, Yuan-Soon Ho, Ying-Jan Wang. Chloroquine Potentiates the Anticancer Effect of Pterostilbene on Pancreatic Cancer by Inhibiting Autophagy and Downregulating the RAGE/STAT3 Pathway. Molecules 2021; 26(21) doi: 10.3390/molecules26216741
|
| 20 |
Yuan Zhou, Maoen Pan, Ronggui Lin, Heguang Huang. Advances in hydrogel materials applied to pancreatic-related diseases. Journal of Pancreatology 2024; 7(3) doi: 10.1097/JP9.0000000000000158
|
| 21 |
Lorenzo Fornaro, Francesco Leone, Angélique Vienot, Andrea Casadei-Gardini, Caterina Vivaldi, Astrid Lièvre, Pasquale Lombardi, Emmanuele De Luca, Dewi Vernerey, Elisa Sperti, Gianna Musettini, Maria Antonietta Satolli, Julien Edeline, Rosella Spadi, Cindy Neuzillet, Alfredo Falcone, Giulia Pasquini, Mario Clerico, Alessandro Passardi, Paola Buscaglia, Aurélia Meurisse, Massimo Aglietta, Clémence Brac, Enrico Vasile, Francesco Montagnani. Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxaliplatin, and Irinotecan. Clinical Colorectal Cancer 2019; 18(4) doi: 10.1016/j.clcc.2019.08.004
|
| 22 |
Mahrou Vahabi, Geng Xu, Amir Avan, Godefridus J. Peters, Elisa Giovannetti. Pharmacological mechanisms underlying the interaction of the nucleoside analogue gemcitabine with the c-MET inhibitor tivantinib in pancreatic cancer. Nucleosides, Nucleotides & Nucleic Acids 2024; 43(8) doi: 10.1080/15257770.2024.2319215
|
| 23 |
Kang Chen, Manxiong Dai, Quanneng Luo, Yi Wang, Weitao Shen, Yan Liao, Yiying Zhou, Wei Cheng. PARP1 controls the transcription of CD24 by ADP-ribosylating the RNA helicase DDX5 in pancreatic cancer. The International Journal of Biochemistry & Cell Biology 2023; 155 doi: 10.1016/j.biocel.2022.106358
|
| 24 |
Wei Sun, Yong Zhang, Xiaolu Ren, Lingzhi Cui, Jianguo Wang, Xiaohong Ni. <i>In Silico</i> Studies, Biological Activities, and Anti-human Pancreatic Cancer Potential of 6-Hydroxy-4-methylcoumarin and 2,5-Dihydroxyacetophenone as Flavonoid Compounds. Journal of Oleo Science 2022; 71(6) doi: 10.5650/jos.ess22021
|
| 25 |
Chiara Deiana, Margherita Agostini, Giovanni Brandi, Elisa Giovannetti. The trend toward more target therapy in pancreatic ductal adenocarcinoma. Expert Review of Anticancer Therapy 2024; 24(7) doi: 10.1080/14737140.2024.2357802
|
| 26 |
Ornella Randazzo, Filippo Papini, Giulia Mantini, Alessandro Gregori, Barbara Parrino, Daniel S. K. Liu, Stella Cascioferro, Daniela Carbone, Godefridus J. Peters, Adam E. Frampton, Ingrid Garajova, Elisa Giovannetti. “Open Sesame?”: Biomarker Status of the Human Equilibrative Nucleoside Transporter-1 and Molecular Mechanisms Influencing its Expression and Activity in the Uptake and Cytotoxicity of Gemcitabine in Pancreatic Cancer. Cancers 2020; 12(11) doi: 10.3390/cancers12113206
|
| 27 |
Xi Cheng, Bingrui Wang, Zhijian Jin, Ding Ma, Weiping Yang, Ren Zhao, Xiaoqian Jing, Baiyong Shen, Chenghong Peng, Weihua Qiu. Pseudomonas aeruginosa-mannose-sensitive hemagglutinin inhibits pancreatic cancer cell proliferation and induces apoptosis via the EGFR pathway and caspase signaling. Oncotarget 2016; 7(47) doi: 10.18632/oncotarget.12844
|
| 28 |
Nele Van Der Steen, Ingrid Garajova, Christian Rolfo, Andrea Cavazzoni, Elisa Giovannetti. Targeting Cell Survival Pathways to Enhance Response to Chemotherapy. 2019; doi: 10.1016/B978-0-12-813753-6.00002-0
|
| 29 |
Isaac James Muyinda, Jae-Gwang Park, Eun-Jung Jang, Byong-Chul Yoo. KRAS, A Prime Mediator in Pancreatic Lipid Synthesis through Extra Mitochondrial Glutamine and Citrate Metabolism. International Journal of Molecular Sciences 2021; 22(10) doi: 10.3390/ijms22105070
|
| 30 |
Monique Williams, Gwen Lomberk, Raul Urrutia. Pancreatic Cancer. 2018; doi: 10.1007/978-1-4939-7193-0_15
|
| 31 |
Annalisa Comandatore, Benoit Immordino, Rita Balsano, Mjriam Capula, Ingrid Garajovà, Joseph Ciccolini, Elisa Giovannetti, Luca Morelli. Potential Role of Exosomes in the Chemoresistance to Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer. Diagnostics 2022; 12(2) doi: 10.3390/diagnostics12020286
|
| 32 |
Theodoros Michelakos, Cristina R. Ferrone. Pancreatic Cancer. 2018; doi: 10.1007/978-1-4939-7193-0_93
|
| 33 |
Ingrid Garajová, Rita Balsano, Heling Wang, Francesco Leonardi, Elisa Giovannetti, Dongmei Deng, Godefridus J. Peters. The role of the microbiome in drug resistance in gastrointestinal cancers. Expert Review of Anticancer Therapy 2021; 21(2) doi: 10.1080/14737140.2021.1844007
|
| 34 |
Prashant Kumar Tiwari, Poojhaa Shanmugam, Vamika Karn, Saurabh Gupta, Richa Mishra, Sarvesh Rustagi, Mandeep Chouhan, Devvret Verma, Niraj Kumar Jha, Sanjay Kumar. Extracellular Vesicular miRNA in Pancreatic Cancer: From Lab to Therapy. Cancers 2024; 16(12) doi: 10.3390/cancers16122179
|
| 35 |
Ingrid Garajová, Rita Balsano, Chiara Tommasi, Elisa Giovannetti. Noncoding Rnas Emerging as Novel Biomarkers in Pancreatic Cancer. Current Pharmaceutical Design 2019; 24(39) doi: 10.2174/1381612825666190119125804
|
| 36 |
E. Giovannetti, C.L. van der Borden, A.E. Frampton, A. Ali, O. Firuzi, G.J. Peters. Never let it go: Stopping key mechanisms underlying metastasis to fight pancreatic cancer. Seminars in Cancer Biology 2017; 44 doi: 10.1016/j.semcancer.2017.04.006
|
| 37 |
A. N. Khitrova, L. V. Bolotina, A. L. Kornietskaya, L. I. Moskvicheva. High-intensity focused ultrasound therapy as part of combined treatment for inoperable pancreatic cancer. Onkologiya. Zhurnal imeni P.A.Gertsena 2020; 9(1) doi: 10.17116/onkolog2020901150
|
| 38 |
Benjamin A. Krantz, Eileen M. O'Reilly. Biomarker-Based Therapy in Pancreatic Ductal Adenocarcinoma: An Emerging Reality?. Clinical Cancer Research 2018; 24(10) doi: 10.1158/1078-0432.CCR-16-3169
|
| 39 |
Mahrou Vahabi, Annalisa Comandatore, Chiara Centra, Giovanni Blandino, Luca Morelli, Elisa Giovannetti. Thinking small to win big? A critical review on the potential application of extracellular vesicles for biomarker discovery and new therapeutic approaches in pancreatic cancer. Seminars in Cancer Biology 2023; 97 doi: 10.1016/j.semcancer.2023.11.003
|
| 40 |
Marika A. Franczak, Ryszard T. Smolenski, Elizabeth C. Comijn, Godefridus J. Peters. Can the combination of 5-fluorouracil and gemcitabine increase the treatment efficacy of pancreatic and colon cancer?. Nucleosides, Nucleotides & Nucleic Acids 2026; doi: 10.1080/15257770.2026.2688509
|
| 41 |
Godefridus J. Peters, Ietje Kathmann, Elisa Giovannetti, Kees Smid, Yehuda G. Assaraf, Gerrit Jansen. The role of l-leucovorin uptake and metabolism in the modulation of 5-fluorouracil efficacy and antifolate toxicity. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1450418
|
| 42 |
Camilla Pecoraro, Barbara Parrino, Stella Cascioferro, Adrian Puerta, Amir Avan, Godefridus J. Peters, Patrizia Diana, Elisa Giovannetti, Daniela Carbone. A New Oxadiazole-Based Topsentin Derivative Modulates Cyclin-Dependent Kinase 1 Expression and Exerts Cytotoxic Effects on Pancreatic Cancer Cells. Molecules 2021; 27(1) doi: 10.3390/molecules27010019
|
| 43 |
Mahrou Vahabi, Bilal Dehni, Inés Antomás, Elisa Giovannetti, Godefridus J. Peters. Targeting miRNA and using miRNA as potential therapeutic options to bypass resistance in pancreatic ductal adenocarcinoma. Cancer and Metastasis Reviews 2023; 42(3) doi: 10.1007/s10555-023-10127-w
|
| 44 |
Daniel Ansari, Fredrik Sambergs, Love Johansson, Roland Andersson. Can protein science solve the unmet needs in pancreatic cancer diagnosis and therapy?. Expert Review of Proteomics 2017; 14(6) doi: 10.1080/14789450.2017.1314787
|
| 45 |
John P. Neoptolemos, David Cunningham, Francesco Sclafani, Paula Ghaneh. Pancreatic Cancer. 2018; doi: 10.1007/978-1-4939-7193-0_43
|
| 46 |
Haiyang Du, Gao Si, Jiqing Si, Xuejie Song, Fuchun Si. Single-cell RNA sequencing analysis revealed malignant ductal cell heterogeneity and prognosis signatures in pancreatic cancer. Clinics and Research in Hepatology and Gastroenterology 2023; 47(8) doi: 10.1016/j.clinre.2023.102200
|
| 47 |
Theodoros Michelakos, Cristina R. Ferrone. Pancreatic Cancer. 2017; doi: 10.1007/978-1-4939-6631-8_93-1
|
| 48 |
Zhengjun Lin, Shiyao Lu, Xubin Xie, Xuyang Yi, He Huang. Noncoding RNAs in drug-resistant pancreatic cancer: A review. Biomedicine & Pharmacotherapy 2020; 131 doi: 10.1016/j.biopha.2020.110768
|
| 49 |
Heike Loeser, Dirk Waldschmidt, Fabian Kuetting, Carina Heydt, Thomas Zander, Patrick Plum, Hakan Alakus, Reinhard Buettner, Alexander Quaas. Copy-number variation and protein expression of DOT1L in pancreatic adenocarcinoma as a potential drug target. Molecular and Clinical Oncology 2017; 6(5) doi: 10.3892/mco.2017.1194
|
| 50 |
Laura L. Meijer, Ingrid Garajová, Chiara Caparello, Tessa Y. S. Le Large, Adam E. Frampton, Enrico Vasile, Niccola Funel, Geert Kazemier, Elisa Giovannetti. Plasma miR-181a-5p Downregulation Predicts Response and Improved Survival After FOLFIRINOX in Pancreatic Ductal Adenocarcinoma. Annals of Surgery 2020; 271(6) doi: 10.1097/SLA.0000000000003084
|
| 51 |
Michael Orth, Philipp Metzger, Sabine Gerum, Julia Mayerle, Günter Schneider, Claus Belka, Maximilian Schnurr, Kirsten Lauber. Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches. Radiation Oncology 2019; 14(1) doi: 10.1186/s13014-019-1345-6
|
| 52 |
Woonghee Lee, Gwonhwa Song, Hyocheol Bae. Matairesinol Induces Mitochondrial Dysfunction and Exerts Synergistic Anticancer Effects with 5-Fluorouracil in Pancreatic Cancer Cells. Marine Drugs 2022; 20(8) doi: 10.3390/md20080473
|
| 53 |
Motahareh Mortazavi, Elaheh Raufi, Tahereh Damghani, Mehdi Khoshneviszadeh, Najmeh Edraki, Masoomeh Eskandari, Elisa Giovannetti, Godefridus J. Peters, Somayeh Pirhadi, Omidreza Firuzi. Discovery of anticancer agents with c-Met inhibitory potential by virtual and experimental screening of a chemical library. European Journal of Pharmacology 2023; 938 doi: 10.1016/j.ejphar.2022.175395
|
| 54 |
Ingrid Garajová, Marianna Peroni, Fabio Gelsomino, Francesco Leonardi. A Simple Overview of Pancreatic Cancer Treatment for Clinical Oncologists. Current Oncology 2023; 30(11) doi: 10.3390/curroncol30110694
|
| 55 |
Muhammad Babar Jamshed, Fahad Munir, Numan Shahid, Ussama Sadiq, Syed Aun Muhammad, Noor Bader Ghanem, Hong Zhong, Xiaokun Li, Qiyu Zhang. Antitumor activity and combined inhibitory effect of ceritinib with gemcitabine in pancreatic cancer. American Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 318(1) doi: 10.1152/ajpgi.00130.2019
|
| 56 |
Stella Cascioferro, Giovanna Li Petri, Barbara Parrino, Btissame El Hassouni, Daniela Carbone, Vincenzo Arizza, Ugo Perricone, Alessandro Padova, Niccola Funel, Godefridus J. Peters, Girolamo Cirrincione, Elisa Giovannetti, Patrizia Diana. 3-(6-Phenylimidazo [2,1-b][1,3,4]thiadiazol-2-yl)-1H-Indole Derivatives as New Anticancer Agents in the Treatment of Pancreatic Ductal Adenocarcinoma. Molecules 2020; 25(2) doi: 10.3390/molecules25020329
|
| 57 |
Pan Liu, Jiarui Feng, Meng Sun, Wen Yuan, Ruijing Xiao, Jie Xiong, Xiaoxin Huang, Meng Xiong, Wu Chen, Xin Yu, Qian Sun, Xiaojie Zhao, Qiuping Zhang, Liang Shao. Synergistic effects of baicalein with gemcitabine or docetaxel on the proliferation, migration and apoptosis of pancreatic cancer cells. International Journal of Oncology 2017; 51(6) doi: 10.3892/ijo.2017.4153
|
| 58 |
Marika Franczak, Barbara Kutryb-Zajac, Btissame El Hassouni, Elisa Giovannetti, Carlotta Granchi, Filippo Minutolo, Ryszard T. Smolenski, Godefridus J. Peters. The effect of lactate dehydrogenase-A inhibition on intracellular nucleotides and mitochondrial respiration in pancreatic cancer cells. Nucleosides, Nucleotides & Nucleic Acids 2022; 41(12) doi: 10.1080/15257770.2022.2031215
|
| 59 |
Arthur T.F. Choy, Ilaria Carnevale, Stefano Coppola, Laura L. Meijer, Geert Kazemier, Egija Zaura, Dongmei Deng, Elisa Giovannetti. The microbiome of pancreatic cancer: from molecular diagnostics to new therapeutic approaches to overcome chemoresistance caused by metabolic inactivation of gemcitabine. Expert Review of Molecular Diagnostics 2018; 18(12) doi: 10.1080/14737159.2018.1544495
|
| 60 |
Laura L. Meijer, Jisce R. Puik, Tessa Y.S. Le Large, Michal Heger, Frederike Dijk, Niccola Funel, Thomas Wurdinger, Ingrid Garajová, Nicole C.T. van Grieken, Mark A. van de Wiel, Elisa Giovannetti, Geert Kazemier. Unravelling the Diagnostic Dilemma: A MicroRNA Panel of Circulating MiR-16 and MiR-877 as A Diagnostic Classifier for Distal Bile Duct Tumors. Cancers 2019; 11(8) doi: 10.3390/cancers11081181
|
| 61 |
John P. Neoptolemos, David Cunningham, Francesco Sclafani, Paula Ghaneh. Pancreatic Cancer. 2016; doi: 10.1007/978-1-4939-6631-8_43-2
|
| 62 |
Pei Pei Che, Alessandro Gregori, Cecilia Bergonzini, Mahsoem Ali, Giulia Mantini, Thomas Schmidt, Francesco Finamore, Stephanie M. Fraga Rodrigues, Adam E. Frampton, Liam A. McDonnell, Erik H. Danen, Ben J. Slotman, Peter Sminia, Elisa Giovannetti. Differential Sensitivity to Ionizing Radiation in Gemcitabine-Resistant and Paclitaxel-Resistant Pancreatic Cancer Cells. International Journal of Radiation Oncology*Biology*Physics 2024; 118(5) doi: 10.1016/j.ijrobp.2023.10.035
|
| 63 |
Nigar Kantarci-Carsibasi, Münteha Girgin, Nursah D. Fidan, Tugba Bal, Shirin Tarbiat. In silico screening and in vitro biological evaluation reveal Queuine as a promising MAP4K4 inhibitor for treating pancreatic cancer. BMC Biotechnology 2025; 25(1) doi: 10.1186/s12896-025-01033-w
|
| 64 |
Ahmed F. Salem, Luca Gambini, Parima Udompholkul, Carlo Baggio, Maurizio Pellecchia. Therapeutic Targeting of Pancreatic Cancer via EphA2 Dimeric Agonistic Agents. Pharmaceuticals 2020; 13(5) doi: 10.3390/ph13050090
|
| 65 |
Ying‐Na Liao, Pei‐Qi Huang, Hong Pan, Yan‐Zhi Gai, Yun‐Fei Zhan, Shu‐Xin Li, Hui‐Zhen Nie. Prolactin receptor potentiates chemotherapy through miRNAs‐induced G6PD/TKT inhibition in pancreatic cancer. The FASEB Journal 2024; 38(10) doi: 10.1096/fj.202302287RR
|
| 66 |
Alessandro Gregori, Cecilia Bergonzini, Mjriam Capula, Giulia Mantini, Fatemeh Khojasteh-Leylakoohi, Annalisa Comandatore, Ghazaleh Khalili-Tanha, Alireza Khooei, Luca Morelli, Amir Avan, Erik H. Danen, Thomas Schmidt, Elisa Giovannetti. Prognostic Significance of Integrin Subunit Alpha 2 (ITGA2) and Role of Mechanical Cues in Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma (PDAC). Cancers 2023; 15(3) doi: 10.3390/cancers15030628
|
| 67 |
Cristoforo Grasso, Gerrit Jansen, Elisa Giovannetti. Drug resistance in pancreatic cancer: Impact of altered energy metabolism. Critical Reviews in Oncology/Hematology 2017; 114 doi: 10.1016/j.critrevonc.2017.03.026
|
| 68 |
Paul Noordhuis, Adrianus C. Laan, Kasper van de Born, Richard J. Honeywell, Godefridus J. Peters. Coexisting Molecular Determinants of Acquired Oxaliplatin Resistance in Human Colorectal and Ovarian Cancer Cell Lines. International Journal of Molecular Sciences 2019; 20(15) doi: 10.3390/ijms20153619
|
| 69 |
Camilla Pecoraro, Beatrice Faggion, Beatrice Balboni, Daniela Carbone, Godefridus J. Peters, Patrizia Diana, Yehuda G. Assaraf, Elisa Giovannetti. GSK3β as a novel promising target to overcome chemoresistance in pancreatic cancer. Drug Resistance Updates 2021; 58 doi: 10.1016/j.drup.2021.100779
|